{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:31:17Z","timestamp":1786480277103,"version":"build-2736575974"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Patients with autosomal dominant polycystic kidney disease benefit from specialized care over their lifetimes, starting with diagnosis of the condition with ongoing discussion of both the renal course and extra-renal issues. Both renal and extra-renal issues may continue to cause major morbidity even after successful kidney transplant or initiation of RRT, and extra-renal disease aspects should always be considered as part of routine management. In this review, we will focus on updates in pain\/depression screening, cardiac manifestations, liver and pancreatic cysts, kidney stone management, and genetic counseling. In some instances, we have shared our current clinical practice rather than an evidence-based guideline. We anticipate more standardization of care after the release of the Kidney Disease Improving Global Outcomes guidelines for management in autosomal dominant polycystic kidney disease later this year.<\/jats:p>","DOI":"10.34067\/kid.0000000000000296","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T10:04:48Z","timestamp":1701079488000},"page":"1806-1815","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Beyond Loss of Kidney Function: Patient Care in Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.34067","volume":"4","author":[{"given":"Marie C.","family":"Hogan","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1276-6567","authenticated-orcid":false,"given":"Kathryn","family":"Simmons","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Ullman","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Gondal","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5809-9961","authenticated-orcid":false,"given":"Neera K.","family":"Dahl","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"issue":"4","key":"B1-20250823","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ndt\/gfx327","article-title":"European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD forum and multispecialist roundtable participants","volume":"33","author":"Harris","year":"2018","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"B2-20250823","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/ndt\/gft437","article-title":"Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management","volume":"29","author":"Luciano","year":"2014","journal-title":"Nephrol Dial Transplant."},{"issue":"12","key":"B3-20250823","first-page":"2106","article-title":"Health-related quality of life across all stages of autosomal dominant polycystic kidney disease","volume":"32","author":"Eriksson","year":"2017","journal-title":"Nephrol Dial Transplant."},{"key":"B4-20250823","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2369-14-179","article-title":"Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study","volume":"14","author":"Suwabe","year":"2013","journal-title":"BMC Nephrol."},{"issue":"3","key":"B5-20250823","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pmn.2009.03.002","article-title":"\u201cAn evil heritage\u201d: interview study of pain and autosomal dominant polycystic kidney disease","volume":"10","author":"Heiwe","year":"2009","journal-title":"Pain Manag Nurs."},{"issue":"2","key":"B6-20250823","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2013.08.017","article-title":"Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study","volume":"63","author":"Miskulin","year":"2014","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B7-20250823","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ndt\/gfv010","article-title":"A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research","volume":"30","author":"Tong","year":"2015","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B8-20250823","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ckj\/sfv060","article-title":"Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians","volume":"8","author":"Baker","year":"2015","journal-title":"Clin Kidney J."},{"issue":"3","key":"B9-20250823","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ckj\/sfab110","article-title":"Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report","volume":"15","author":"Natale","year":"2022","journal-title":"Clin Kidney J."},{"issue":"2","key":"B10-20250823","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2215\/CJN.0000000000000034","article-title":"Development of a patient-reported outcomes tool to assess pain and discomfort in autosomal dominant polycystic kidney disease","volume":"18","author":"Oberdhan","year":"2023","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B11-20250823","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2215\/CJN.0000000000000043","article-title":"An objective pain assessment for autosomal dominant polycystic kidney disease (ADPKD): a patient's perspective","volume":"18","author":"Hoggan","year":"2023","journal-title":"Clin J Am Soc Nephrol."},{"issue":"7424","key":"B12-20250823","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/bmj.327.7424.1144","article-title":"Screening for depression in primary care with two verbally asked questions: cross sectional study","volume":"327","author":"Arroll","year":"2003","journal-title":"BMJ."},{"issue":"10","key":"B13-20250823","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1681\/ASN.2018060590","article-title":"A practical guide for treatment of rapidly progressive ADPKD with tolvaptan","volume":"29","author":"Chebib","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"B14-20250823","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2215\/CJN.03960318","article-title":"Recent advances in the management of autosomal dominant polycystic kidney disease","volume":"13","author":"Chebib","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"issue":"7","key":"B15-20250823","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/ndt\/gfv299","article-title":"Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease","volume":"31","author":"Simms","year":"2016","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"B16-20250823","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1590\/S0101-28002011000200002","article-title":"Ansiedade, depress\u00e3o e qualidade de vida em pacientes com glomerulonefrite familiar ou doen\u00e7a renal polic\u00edstica autoss\u00f4mica dominante","volume":"33","author":"Barros","year":"2011","journal-title":"Jornal brasileiro de nefrologia."},{"issue":"4","key":"B17-20250823","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11255-022-03375-2","article-title":"The relationship between depression, anxiety, quality of life levels, and the chronic kidney disease stage in the autosomal dominant polycystic kidney disease","volume":"55","author":"Yarlioglu","year":"2023","journal-title":"Int Urol Nephrol."},{"key":"B18-20250823","first-page":"1","article-title":"Acceptance of illness, satisfaction with life, and emotional control in the early stage of autosomal dominant polycystic kidney disease [published online ahead of print October 12, 2022]","author":"Jankowska","year":"2022","journal-title":"Nephron."},{"issue":"5","key":"B19-20250823","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/1570161118999200918094809","article-title":"Cardiovascular risk and quality of life in autosomal dominant polycystic kidney disease patients on therapy with tolvaptan: a pilot study","volume":"19","author":"Lai","year":"2021","journal-title":"Curr Vasc Pharmacol."},{"issue":"2","key":"B20-20250823","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.xkme.2019.11.008","article-title":"Quality of life in autosomal dominant polycystic kidney disease patients treated with tolvaptan","volume":"2","author":"Anderegg","year":"2020","journal-title":"Kidney Med."},{"issue":"7","key":"B21-20250823","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.nephro.2016.12.005","article-title":"Quality of life in patients with autosomal dominant polycystic kidney disease","volume":"13","author":"Lecardeur","year":"2017","journal-title":"Nephrol Ther."},{"issue":"5","key":"B22-20250823","doi-asserted-by":"crossref","first-page":"606","DOI":"10.34067\/KID.0000000000000087","article-title":"Association between depressive symptom trajectory and CKD progression: findings from the chronic renal insufficiency cohort (CRIC) study","volume":"4","author":"Missikpode","year":"2023","journal-title":"Kidney360."},{"issue":"4","key":"B23-20250823","article-title":"Screening for depression in adults: recommendation statement","volume":"94","year":"2016","journal-title":"Am Fam Physician."},{"issue":"10174","key":"B24-20250823","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet."},{"issue":"2","key":"B25-20250823","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.ackd.2009.12.001","article-title":"Diagnosis and screening of autosomal dominant polycystic kidney disease","volume":"17","author":"Pei","year":"2010","journal-title":"Adv Chronic Kidney Dis."},{"issue":"3","key":"B26-20250823","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00467-021-04974-4","article-title":"The wind of change in the management of autosomal dominant polycystic kidney disease in childhood","volume":"37","author":"Gimpel","year":"2022","journal-title":"Pediatr Nephrol."},{"issue":"5","key":"B27-20250823","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/humrep\/dez027","article-title":"Factors influencing the clinical outcome of preimplantation genetic testing for polycystic kidney disease","volume":"34","author":"Berckmoes","year":"2019","journal-title":"Hum Reprod."},{"issue":"1","key":"B28-20250823","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B29-20250823","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.28545","article-title":"Development and validation of a disease-specific questionnaire to assess patient-reported symptoms in polycystic liver disease","volume":"64","author":"Neijenhuis","year":"2016","journal-title":"Hepatology."},{"issue":"8","key":"B30-20250823","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/ndt\/gfab040","article-title":"A practical guide for the management of acute abdominal pain with fever in patients with autosomal dominant polycystic kidney disease","volume":"37","author":"Jouret","year":"2022","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B31-20250823","first-page":"1282","article-title":"Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease","volume":"26","author":"Sherstha","year":"1997","journal-title":"Hepatology."},{"issue":"6","key":"B32-20250823","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.1840110619","article-title":"Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease","volume":"11","author":"Gabow","year":"1990","journal-title":"Hepatology."},{"issue":"8","key":"B33-20250823","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneph.2014.104","article-title":"Renal transplantation in autosomal dominant polycystic kidney disease","volume":"10","author":"Kanaan","year":"2014","journal-title":"Nat Rev Nephrol."},{"issue":"3","key":"B34-20250823","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/pr.2014.198","article-title":"Development of a pediatric-specific clinical probability tool for diagnosis of venous thromboembolism: a feasibility study","volume":"77","author":"Kerlin","year":"2015","journal-title":"Pediatr Res."},{"issue":"6","key":"B35-20250823","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/ndt\/gfw008","article-title":"Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease","volume":"31","author":"Chebib","year":"2016","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"B36-20250823","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2215\/CJN.08660621","article-title":"Volume progression and imaging classification of polycystic liver in early autosomal dominant polycystic kidney disease","volume":"17","author":"Bae","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"B37-20250823","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/cpt.1553","article-title":"Estrogen-containing oral contraceptives are associated with polycystic liver disease severity in premenopausal patients","volume":"106","author":"van Aerts","year":"2019","journal-title":"Clin Pharmacol Ther."},{"issue":"1","key":"B38-20250823","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cgh.2014.07.051","article-title":"Liver involvement in early autosomal-dominant polycystic kidney disease","volume":"13","author":"Hogan","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"9","key":"B39-20250823","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/liv.14986","article-title":"Estrogens in polycystic liver disease: a target for future therapies?","volume":"41","author":"Aapkes","year":"2021","journal-title":"Liver Int."},{"issue":"2","key":"B40-20250823","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrgastro.2012.254","article-title":"Diagnosis and management of polycystic liver disease","volume":"10","author":"Gevers","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"1","key":"B41-20250823","doi-asserted-by":"crossref","first-page":"e032620","DOI":"10.1136\/bmjopen-2019-032620","article-title":"Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis","volume":"10","author":"Griffiths","year":"2020","journal-title":"BMJ Open."},{"issue":"2","key":"B42-20250823","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.gastro.2013.04.055","article-title":"Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data","volume":"145","author":"Gevers","year":"2013","journal-title":"Gastroenterology."},{"issue":"4","key":"B43-20250823","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/liv.12986","article-title":"Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysis","volume":"36","author":"Gevers","year":"2016","journal-title":"Liver Int."},{"issue":"1","key":"B44-20250823","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/SLA.0b013e3181ad83dc","article-title":"Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation","volume":"250","author":"Schnelldorfer","year":"2009","journal-title":"Ann Surg."},{"issue":"6","key":"B45-20250823","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.xkme.2019.07.015","article-title":"Foam sclerotherapy for cyst volume reduction in autosomal dominant polycystic kidney disease: a prospective cohort study","volume":"1","author":"Iliuta","year":"2019","journal-title":"Kidney Med."},{"issue":"6","key":"B47-20250823","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/hep.24036","article-title":"Medical and surgical treatment options for polycystic liver disease","volume":"52","author":"Drenth","year":"2010","journal-title":"Hepatology."},{"issue":"1","key":"B49-20250823","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12876-021-01703-x","article-title":"Liver transplantation in adult polycystic liver disease: the Ontario experience","volume":"21","author":"Alsager","year":"2021","journal-title":"BMC Gastroenterol."},{"issue":"5","key":"B50-20250823","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/MPA.0000000000001306","article-title":"Pancreatic cysts and intraductal papillary mucinous neoplasm in autosomal dominant polycystic kidney disease","volume":"48","author":"McNicholas","year":"2019","journal-title":"Pancreas."},{"issue":"1","key":"B51-20250823","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00384-020-03736-2","article-title":"Colonic diverticular disease in autosomal dominant polycystic kidney disease: is there really an association? A nationwide analysis","volume":"36","author":"Duarte-Chavez","year":"2021","journal-title":"Int J Colorectal Dis."},{"issue":"5","key":"B52-20250823","first-page":"615","article-title":"Abdominal wall hernia in autosomal dominant polycystic kidney disease","volume":"84","author":"Morris-Stiff","year":"1997","journal-title":"Br J Surg."},{"key":"B53-20250823","first-page":"84","article-title":"Indirect inguinal hernia in CAPD patients with polycystic kidney disease","volume":"5","author":"Modi","year":"1989","journal-title":"Adv Perit Dial."},{"issue":"2","key":"B54-20250823","doi-asserted-by":"crossref","first-page":"126","DOI":"10.34067\/KID.0000000000000066","article-title":"Defining cardiac dysfunction in ADPKD","volume":"4","author":"Kuo","year":"2023","journal-title":"Kidney360."},{"issue":"12","key":"B55-20250823","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/ndt\/gft513","article-title":"Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease","volume":"29","author":"Rahbari-Oskoui","year":"2014","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"B56-20250823","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD score: a new Algorithm to predict renal survival in autosomal dominant polycystic kidney disease","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B57-20250823","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2215\/CJN.11401017","article-title":"Prevalence of hypertension in children with early-stage ADPKD","volume":"13","author":"Massella","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B58-20250823","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1681\/ASN.V1051020","article-title":"Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease","volume":"10","author":"Valero","year":"1999","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B59-20250823","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/0886022X.2020.1864403","article-title":"Morning blood pressure surge in early autosomal dominant polycystic kidney disease and its relation with left ventricular hypertrophy","volume":"43","author":"Yildiz","year":"2021","journal-title":"Ren Fail."},{"issue":"8","key":"B60-20250823","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease","volume":"8","author":"Chapman","year":"1997","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"B61-20250823","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.2215\/CJN.04610511","article-title":"Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease","volume":"6","author":"Perrone","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B62-20250823","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12882-019-1555-z","article-title":"Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients","volume":"20","author":"Chen","year":"2019","journal-title":"BMC Nephrol."},{"issue":"2","key":"B63-20250823","doi-asserted-by":"crossref","first-page":"150","DOI":"10.34067\/KID.0002942022","article-title":"Cardiac manifestations in patients with autosomal dominant polycystic kidney disease (ADPKD): a single-center study","volume":"4","author":"Arjune","year":"2023","journal-title":"Kidney360."},{"key":"B64-20250823","first-page":"1","article-title":"The pathophysiology of left ventricular hypertrophy, beyond hypertension, in autosomal dominant polycystic kidney disease [published online ahead of print July 27, 2022]","author":"Oto","year":"2022","journal-title":"Nephron."},{"issue":"3S","key":"B65-20250823","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","year":"2021","journal-title":"Kidney Int."},{"issue":"4","key":"B66-20250823","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.kint.2020.04.053","article-title":"Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease","volume":"98","author":"Kramers","year":"2020","journal-title":"Kidney Int."},{"issue":"25 suppl 2","key":"B67-20250823","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation."},{"issue":"20","key":"B68-20250823","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.3390\/jcm11205982","article-title":"Echocardiographic abnormalities in autosomal dominant polycystic kidney disease (ADPKD) patients","volume":"11","author":"Pfeferman","year":"2022","journal-title":"J Clin Med."},{"issue":"14","key":"B69-20250823","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM198810063191404","article-title":"Echocardiographic findings in autosomal dominant polycystic kidney disease","volume":"319","author":"Hossack","year":"1988","journal-title":"New Engl J Med."},{"issue":"6","key":"B70-20250823","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s40620-022-01309-w","article-title":"Does autosomal dominant polycystic kidney disease increase the risk of aortic aneurysm or dissection: a point of view based on a systematic review and meta-analysis","volume":"35","author":"Nunes","year":"2022","journal-title":"J Nephrol."},{"issue":"22","key":"B71-20250823","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1001\/jama.2019.17021","article-title":"Primary care screening for abdominal aortic aneurysm: updated evidence report and systematic review for the US preventive Services task force","volume":"322","author":"Guirguis-Blake","year":"2019","journal-title":"JAMA."},{"issue":"4","key":"B72-20250823","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/jcm11041127","article-title":"Pericardial effusion on MRI in autosomal dominant polycystic kidney disease","volume":"11","author":"Liu","year":"2022","journal-title":"J Clin Med."},{"issue":"6","key":"B73-20250823","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2215\/CJN.01920507","article-title":"Increased occurrence of pericardial effusion in patients with autosomal dominant polycystic kidney disease","volume":"2","author":"Qian","year":"2007","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B74-20250823","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ekir.2017.05.014","article-title":"Autosomal dominant polycystic kidney patients may Be predisposed to various cardiomyopathies","volume":"2","author":"Chebib","year":"2017","journal-title":"Kidney Int Rep."},{"key":"B75-20250823","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2013.01.015","article-title":"Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy","volume":"58","author":"Paavola","year":"2013","journal-title":"J Mol Cell Cardiol."},{"issue":"6","key":"B76-20250823","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.34067\/KID.0007422020","article-title":"Examining the role of novel CKD therapies for the ADPKD patient","volume":"2","author":"Patel","year":"2021","journal-title":"Kidney360."},{"issue":"6","key":"B77-20250823","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.semnephrol.2015.10.012","article-title":"KHA-CARI autosomal dominant polycystic kidney disease guideline: management of renal stone disease","volume":"35","author":"Mallett","year":"2015","journal-title":"Semin Nephrol."},{"key":"B78-20250823","doi-asserted-by":"crossref","first-page":"20543581211000227","DOI":"10.1177\/20543581211000227","article-title":"Risk of hospital encounters with kidney stones in autosomal dominant polycystic kidney disease: a cohort study","volume":"8","author":"Kalatharan","year":"2021","journal-title":"Can J Kidney Health Dis."},{"issue":"4","key":"B79-20250823","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2215\/CJN.03100608","article-title":"Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients","volume":"4","author":"Nishiura","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B80-20250823","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/ajkd.2000.8266","article-title":"Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease","volume":"36","author":"Grampsas","year":"2000","journal-title":"Am J Kidney Dis."},{"issue":"10","key":"B81-20250823","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1172\/JCI128503","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"129","author":"Torres","year":"2019","journal-title":"J Clin Invest."},{"issue":"12","key":"B82-20250823","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.34067\/KID.0004772022","article-title":"Urinary citrate is associated with kidney outcomes in early polycystic kidney disease","volume":"3","author":"Rocha","year":"2022","journal-title":"Kidney360."},{"issue":"1","key":"B83-20250823","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int."},{"issue":"2","key":"B84-20250823","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2215\/CJN.08940813","article-title":"Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney disease","volume":"9","author":"Rahbari-Oskoui","year":"2014","journal-title":"Clin J Am Soc Nephrol."},{"issue":"10","key":"B85-20250823","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1089\/end.2010.0093","article-title":"Nephrolithiasis in autosomal dominant polycystic kidney disease","volume":"24","author":"Mufti","year":"2010","journal-title":"J Endourol."},{"issue":"7","key":"B86-20250823","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/end.2020.0827","article-title":"Percutaneous nephrolithotomy under X-ray-free technique in upper urinary stone patients with autosomal dominant polycystic kidney disease: experience from a large-volume stone management center","volume":"35","author":"Xiao","year":"2021","journal-title":"J Endourol."},{"issue":"7","key":"B87-20250823","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2215\/CJN.13861119","article-title":"Urinary lithogenic risk profile in ADPKD patients treated with tolvaptan","volume":"15","author":"Bargagli","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B88-20250823","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ki.1994.151","article-title":"Intracranial aneurysms in autosomal dominant polycystic kidney disease","volume":"45","author":"Chauveau","year":"1994","journal-title":"Kidney Int."},{"issue":"12","key":"B89-20250823","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","article-title":"Causes of death in autosomal dominant polycystic kidney disease","volume":"5","author":"Fick","year":"1995","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B90-20250823","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1053\/ajkd.2001.26116","article-title":"Chronic subdural hematoma in a 50-year-old man with polycystic kidney disease","volume":"38","author":"Holthouse","year":"2001","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B91-20250823","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0272-6386(00)70299-X","article-title":"Chronic subdural hematoma in autosomal dominant polycystic kidney disease","volume":"35","author":"Wijdicks","year":"2000","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B92-20250823","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1440-1797.2004.00270.x","article-title":"Chronic subdural haematoma and autosomal polycystic kidney disease: report of two new cases","volume":"9","author":"Abderrahim","year":"2004","journal-title":"Nephrology (Carlton)."},{"issue":"15","key":"B93-20250823","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2169\/internalmedicine.55.6295","article-title":"Dialysis-induced subdural hematoma in an arachnoid cyst associated with autosomal dominant polycystic kidney disease","volume":"55","author":"Takata","year":"2016","journal-title":"Intern Med."},{"issue":"10","key":"B94-20250823","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrneph.2015.128","article-title":"Vascular complications in autosomal dominant polycystic kidney disease","volume":"11","author":"Perrone","year":"2015","journal-title":"Nat Rev Nephrol."},{"issue":"1","key":"B95-20250823","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/STROKEAHA.110.578740","article-title":"Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease","volume":"42","author":"Xu","year":"2011","journal-title":"Stroke."},{"issue":"2","key":"B96-20250823","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1148\/radiol.2019181399","article-title":"MR angiography screening and surveillance for intracranial aneurysms in autosomal dominant polycystic kidney disease: a cost-effectiveness analysis","volume":"291","author":"Malhotra","year":"2019","journal-title":"Radiology."},{"issue":"1","key":"B97-20250823","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2369-15-39","article-title":"Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease","volume":"15","author":"Yoo","year":"2014","journal-title":"BMC Nephrol."},{"issue":"6","key":"B98-20250823","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2215\/CJN.09731110","article-title":"Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease","volume":"6","author":"Irazabal","year":"2011","journal-title":"Clin J Am Soc Nephrol."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000000000296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:01:00Z","timestamp":1786478460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000000000296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":96,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000000000296","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"2023-03-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}